![]() Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. | ![]() Italfarmaco Italfarmaco is a pharmaceutical company providing products in the cardiovascular, immuno-oncologic, and gynecological areas. | ||||
Founding Date | Founding Date 1953 | Founding Date 1944 | Founding Date 1980 | Founding Date 2010 | Founding Date 1938 |
Type | Type Subsidiary | Type Subsidiary | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Houston, US HQ Conroe, US Houston, US Houston, US Houston, US League City, US Sugar Land, US | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more | Locations TW HQ | Locations Cinisello Balsamo, IT HQ Paleo Faliro, GR Milano, IT Algés, PT Moskva, RU Alcobendas, ES Berwyn, US | |
Employees | Employees 17,3684% decrease | Employees 22,1641% increase | Employees 25,200 | Employees 76 | Employees 3,043 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $6b (FY, 2022) | Revenue (est.) $36.8b (FY, 2025) | Revenue (est.) NT$1.3b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $12b (FY, 2025) | Cost of goods NT$629m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $24.7b (FY, 2025) | Gross profit NT$709.7m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income ($297.5m) (FY, 2022) | Net income $7.7b (FY, 2025) | Net income NT$187.8m (FY, 2025) | Net income N/A |
MD Anderson Cancer Center is a cancer treatment center.
View company
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View company
TSH Biopharm (東生華製藥股份有限公司) is a pharmaceutical company focused on chronic diseases.
View company
Italfarmaco is a pharmaceutical company providing products in the cardiovascular, immuno-oncologic, and gynecological areas.
View company